CSP 571 - Drug-eluting Stents vs. Bare Metal Stents in Saphenous Vein Graft Angioplasty (DIVA)

Trial Profile

CSP 571 - Drug-eluting Stents vs. Bare Metal Stents in Saphenous Vein Graft Angioplasty (DIVA)

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Aug 2017

At a glance

  • Drugs Clopidogrel (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms DIVA
  • Most Recent Events

    • 25 Aug 2017 The study follow-up ended on December 31, 2016.
    • 25 Aug 2017 Trial enrollment was terminated on December 31, 2015 due to slower enrollment than expected and funding considerations.
    • 25 Aug 2017 Trial design published in the Clinical Cardiology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top